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Abstract
Rationale Alcoholism is a primary, chronic relapsing disease
of brain reward, motivation, memory, and related circuitry. It
is characterized by an individual’s continued drinking despite
negative consequences related to alcohol use, which is exem-
plified by alcohol use leading to clinically significant impair-
ment or distress. Chronic alcohol consumption increases the
expression of innate immune signaling molecules (ISMs) in
the brain that alter cognitive processes and promote alcohol
drinking.
Objectives Unraveling the mechanisms of alcohol-induced
neuroimmune gene induction is complicated by positive loops
of multiple cytokines and other signaling molecules that con-
verge on nuclear factor kappa-light-chain-enhancer of activat-
ed B cells and activator protein-1 leading to induction of ad-
ditional neuroimmune signaling molecules that amplify and
expand the expression of ISMs.
Results Studies from our laboratory employing reverse tran-
scription polymerase chain reaction (RT-PCR) to assess
mRNA, immunohistochemistry and Western blot analysis to
assess protein expression, and others suggest that ethanol in-
creases brain neuroimmune gene and protein expression
through two distinct mechanisms involving (1) systemic in-
duction of innate immune molecules that are transported from
blood to the brain and (2) the direct release of high-mobility
group box 1 (HMGB1) from neurons in the brain. Released
HMGB1 signals through multiple receptors, particularly Toll-
like receptor (TLR) 4, that potentiate cytokine receptor re-
sponses leading to a hyperexcitable state that disrupts neuro-
nal networks and increases excitotoxic neuronal death. Innate
immune gene activation in brain is persistent, consistent with
the chronic relapsing disease that is alcoholism. Expression of
HMGB1, TLRs, and other ISMs is increased several-fold in
the human orbital frontal cortex, and expression of these mol-
ecules is highly correlated with each other as well as lifetime
alcohol consumption and age of drinking onset.
Conclusions The persistent and cumulative nature of alcohol
on HMGB1 and TLR gene induction support their involve-
ment in alcohol-induced long-term changes in brain function
and neurodegeneration.
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Introduction: microglia and innate immune genes
Microglia are tissue-specific monocyte-like cells of mesoder-
mal origin (Ginhoux et al. 2010), whereas all other brain cells
are derived from the neuroectoderm. Monocytes and tissue-
specific monocyte-like cells (e.g., microglia) express innate
immune signaling molecules originally characterized within
the peripheral immune system. In the brain, microglia consti-
tutively express Toll-like receptor (TLR) 4 and other innate
immune receptors that are responsive to proinflammatory sig-
nals like high-mobility group box 1 (HMGB1) but are also
responsive to neurotransmitters (Kettenmann et al. 2013).
Innate immune gene upregulation with rapid monocyte re-
sponses to infection was first characterized in blood as acute
phase response proteins that today are known to include mul-
tiple cytokines, chemokines, proteases, cellular oxidases, and
cytokine receptors. Acute phase responses and monocyte ac-
tivation involve amplification in the expression of a large
number of genes through kinase signaling pathways that
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converge on two distinct transcription factors: nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB) and
activator protein-1 (AP-1). Both NF-κB and AP-1 induction
promote the expression of innate immune cytokines (Li and
Verma 2002; Valles et al. 2004), including tumor necrosis
factor-alpha (TNFα) and interleukin-1beta (IL-1β) as well
as upregulation of TLRs and other cytokine receptors. In ad-
dition, innate immune proteases and oxidases are induced,
particularly cyclooxygenase (COX-2) and nicotinamide ade-
nine dinucleotide phosphate oxidase (NADPH oxidase) as
well as major histocompatibility (MHC) signaling molecules,
such as beta-2 microglobulin. These monocyte-microglial-
expressed proteins and their receptors are innate immune sig-
naling molecules (ISMs) that are expressed in the brain
(Blanco and Guerri 2007; Guerri and Pascual 2010; Valles
et al. 2004). This review will refer to these brain signaling
molecules as Bneuroimmune^ due to their characterization in
the immune system of the brain, while recognizing that sig-
naling across multiple unique brain cells differs from immune
inflammation in response to infection.
Brain neuroimmune signaling primarily involves
monocyte-microglial innate immune signals and not adaptive
immune antibodies. Although microglia are unique tissue-
specific brain monocyte-like cells, similar to all monocytes,
microglia undergo morphological changes that characterize
stages of activation (Graeber 2010) (Fig. 1). Resting ramified
microglia likely contribute trophic and other signals similar to
the wound healing monocyte phenotype termed M2 that upon
activation can become hyper-ramified, with secretion of
proinflammatory cytokine signals (Beynon and Walker
2012). However, activated microglia do not necessarily al-
ways adopt an M1 phenotype as Marshall et al. (2013) found
that young adult rats subjected to a 4-day binge model of
alcohol led to partial microglial activation as evidenced by
increased expression of OX-42 but not a fully activated phe-
notype characterized by expression of OX-6 or ED-1. This
partial microglial action was accompanied by an increase in
the anti-inflammatory cytokine IL-10 and no increase in pro-
inflammatory cytokines IL-6 or TNFα. Further proinflamma-
tory activation, known as M1 monocyte phenotype, involves
expansion of processes to a Bbushy morphology^ and finally a
Bphagocytic^ rounded morphology (Colton 2009). The rela-
tionship between morphological changes in monocyte-like
cells including microglia and the secretion of ISM is poorly
understood, although increased severity of pathology is asso-
ciated with greater ISM induction and activated morphology.
Like all monocytes, microglial activation can lead to
NF-κB transcription of proinflammatory genes, which signal
to other microglia as well as astroglia, oligodendroglia, and
neurons, amplifying neuroimmune gene induction within and
across cells by induction of TLRs and cytokine receptors,
many belonging to the IL-1β receptor family that activate
kinase cascades that converge on NF-κB (Blanco and Guerri
2007; Blanco et al. 2004, 2005; Fernandez-Lizarbe et al. 2009,
2013; Pascual et al. 2011b; Valles et al. 2004). The amplifica-
tion of ISMs across cells and tissue can lead to pathology, and
understanding the processes of monocyte signaling provides
insight into microglial signaling in brain. The most severe
Fig. 1 Activated morphology of microglia. Representative schematics
and pho tomic rographs of human bra in mic rog l i a ( Iba1
immunohistochemistry) depicting morphological stages of microglial
activation. Ramified or Bresting^ microglia are characterized by long,
ramified processes with comparatively small cell bodies. Mildly
activated hyper-ramified microglia are characterized by increased
branching of processes as well as lengthening of processes and the
secretion of proinflammatory cytokines (Beynon and Walker 2012).
Bushy morphology is intermediate activation and is characterized by
swollen, truncated processes, and enlarged cell bodies. Amoeboid or
Bphagocytic^ microglia are characterized rounded macrophage-like
morphology with no or few processes and are associated with maximal
proinflammatory activation, oxidative-free radicals, and microglial
apoptosis (Kreutzberg 1996; Raivich et al. 1999). Post-mortem human
brains from controls and alcoholics contain all of these subtypes likely
due in part to age-related changes in all individuals. Alcoholics havemore
microglial markers indicative of hyper-ramified morphology in alcoholics
increasing staining compared to control ramified less dense staining.
Figure adapted from He and Crews (2008) and Beynon and Walker
(2012)
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acute example of monocyte activation during infection is sep-
sis. Sepsis and the systemic inflammatory response syndrome
refer to a Bcytokine storm,^ which involves a pronounced
increase in multiple proinflammatory cytokines and other
ISMs that cause a potentially fatal innate immune reaction
consisting of positive feed-forward loops between cytokines
and immune and tissue cells that result in highly elevated
cytokine blood levels, multi-organ failure, and death
(Osterholm 2005). Models of sepsis that involve activation
of an acute phase-like response lead to increased expression
of multiple cytokines that are induced in distinct phases.
During the initial phase, TNFα and IL-1β expression is in-
creased during the first several hours after innate immune
activation and then subside. The second phase involves
HMGB1, which is an agonist at multiple receptors that con-
tribute to further activation of proinflammatory cascades
(Fig. 2). Disulfide-HMGB1 is a TLR4 agonist (Tang et al.
2012), and thiol-HMGB1 is an agonist at the receptor for
advanced glycation end products (RAGE; Allette et al.
2014) and also dimerizes with proinflammatory molecules
(Tang et al. 2012; Venereau et al. 2012), such as IL-1β
(Wahamaa et al. 2011) that enhances IL-1β receptor induction
of proinflammatory molecules through NF-κB. HMGB1 in-
creases in blood approximately 16 h after infection in models
of sepsis and persists for several days during which mice
die. Mortality is prevented by anti-HMGB1 antibody treat-
ment (Wang et al. 2001) consistent with HMGB1 induction
of a Bcytokine storm^ by acting through multiple receptors
that converge on proinflammatory NF-κB signaling.
Survivors of sepsis models show prolonged increases in
serum HMGB1 and cognitive deficits that are blunted with
HMGB1 antibody treatment (Chavan et al. 2012). To model
alcoholic hepatitis and alcohol-induced release of gut endo-
toxin, we systemically administer lipopolysaccharide (LPS)
and polyinos in ic :polycytudyl ic ac id (poly I :C) .
Administration of these endotoxins systemically after eth-
anol treatment exacerbates the innate immune response.
Acute binge drinking also increases serum endotoxin levels
albeit at a lower level observed under septic conditions.
High binge drinking doses cause the gut to become perme-
able or Bleaky^ (Ferrier et al. 2006). Only high doses of
ethanol, e.g., at least 2–3 g/kg ETOH intragastric doses
(Ferrier et al. 2006), potentiate gut innate immune signal-
ing, disrupting gut tight junctions, and opening sites that
allow the gut biome bacteria and their endotoxins to enter
the portal circulation leading to the liver where they can
initiate a proinflammatory response (Sims et al. 2010).
Released LPS potentiates alcohol-induced liver inflamma-
tion and secretion of proinflammatory cytokines, including
the proinflammatory cytokine TNFα, which is released into
the blood. Proinflammatory cytokines in the blood are
transported across the blood–brain barrier (Banks and
Erickson 2010; Qin et al. 2007) such that both cytokines
and alcohol enter the brain where they induce neuroimmune
activation.
Innate immune signaling molecules in the brain appear to
contribute to both brain health and pathology. Indeed, recent
studies find that MHC molecules contribute not only to most
neurodegenerative diseases (Gage 2002; Glass et al. 2010) as
well as alcohol and drug dependence (Crews 2012) but are
also critically involved in brain development (Huh et al.
2000). Within the brain microglia, innate immune cytokines,
such as TNFα, IL-1β, and HMGB1 as well as TLRs,
purinergic receptors (e.g., P2X7), various cytokine receptors,
and innate immune proteases and oxidases, all amplify
Fig. 2 High-mobility group box 1 (HMGB1) is actively and/or passively
released leading to multiple signaling pathways. Actively released
HMGB1 from brain slice cultures found histochemical evidence of
release from neurons by ethanol (Zou and Crews 2014), although
HMGB1 release likely occurs from most brain cell types. Neurons and
glia release HMGB1 during glutamate excitation (Maroso et al. 2010,
2011). HMGB1 is also released during necrotic cell death activating
innate immune signaling. HMGB1 has multiple signaling mechanisms
regulated by oxidation of cysteines. Fully oxidized HMGB1 (blue, left)
does not activate proinflammatory signaling, although it may contribute
to resolution of the proinflammatory state. HMGB1 in the all-thiol form
(yellow, middle) is an agonist at the receptor for advanced glycation end-
products (RAGE; Allette et al. 2014). All-thiol-HMGB1 also forms
heterodimers with proinflammatory molecules such as interleukin-1beta
(IL-1β; Wahamaa et al. 2011) with the HMGB1-IL1 heterodimer
synergistically enhancing stimulation of the IL-1β receptor leading to
proinflammatory gene induction through activation of NF-κB
transcription (Venereau et al. 2012). Disulfide-HMGB1 (red, right)
activates Toll-like receptor 4 (TLR4) also leading to nuclear
translocation of nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-κB) and induction of proinflammatory cytokines. Adapted
from Tang et al. (2012)
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through NF-κB and AP-1 loops that confound studies that are
focused on studying a single neuroimmune signaling mole-
cule (Fig. 3). NF-κB regulates the transcription of proinflam-
matory innate immune genes as well as many other genes
(Perkins 2007). Ethanol increases NF-κB–DNA binding and
expression of multiple innate immune genes including proin-
flammatory cytokines, TNFα, IL-1β, and MCP-1, the proin-
flammatory oxidase, iNOS, and proteases TACE and tPA
(Zou and Crews 2010). Previously, we found that ethanol
increased NF-κB p65 nuclear immunohistochemistry consis-
tent with NF-κB p50⁄p65 subunit nuclear translocation and
transcription activation. Similarly, we found that antibodies
to p50 or p65 super-shifted EMSA gels, suggesting that etha-
nol increased brain NF-κB p65–p50 heterodimer–DNA bind-
ing (Zou and Crews 2006). Taken together, ethanol-induced
NF-κB–DNA binding and target gene expression support eth-
anol activation of NF-κB transcription of proinflammatory
genes. However, using an ELISA-based DNA binding analy-
sis, we found large increases in NF-κB subunit p50 protein but
not NF-κB p65 protein. A similar finding has been reported
for prefrontal cortex gene expression in the post-mortem hu-
man alcoholic brain (Okvist et al. 2007). Array analysis of
gene expression in post-mortem alcoholic prefrontal cortex
found 479 transcripts with NF-κB–DNA binding sites that
were generally upregulated, with analysis of NF-κB subunit
proteins indicating NF-κB p50 was the dominant subunit
expressed in human alcoholic brain (Okvist et al. 2007).
Although homodimers of NF-κB p50 inhibit transcription
(Perkins 2007), increases in NF-κB p50 protein are often as-
sociated with increased transcription. Several mechanisms are
involved in increased NF-κB p50 activation of transcription
including protease processing of inhibitory NF-κB p105 to
transcriptionally active NF-κB p50 (Hoffmann et al. 2006)
or through NF-κB p50 homodimer association with BCL3,
atypical IκB, and other proteins that activate gene transcrip-
tion involving NF-κB p50 (Ghosh and Hayden 2008). Thus,
an increase in NF-κB p50 is consistent with increased NF-κB
gene transcription. Although transcription is complex,
ethanol-induced progressive increases in NF-κB–DNA bind-
ing and increased transcription likely represent one mecha-
nism of ethanol induction amplification of brain innate im-
mune genes. The mechanisms that regulate innate immune
gene induction in various brain cells that contribute in vivo
to amplification of specific innate immune genes are poorly
understood. In the current review, literature pertaining to al-
coholism and innate immunity was reviewed using the
PubMed search engine, and this review will focus on two
mechanisms of ethanol sensitization of microglia and induc-
tion of neuroimmune genes. The first involves a systemic
mechanism whereby blood innate immune signaling mole-
cules induce brain neuroimmune genes and a second local
mechanism involving neuronal–glial signaling through
neuroimmune genes that regulate neuronal excitability. It
should be noted that neuroimmune activation appears to be
involved in the later stages of heavy drinking and that binge
drinking is required to activate the innate immune system.
Ethanol-induced blood innate immune signals activate
brain neuroimmune signaling
Acute binge drinking increases blood cytokines in normal
healthy humans (Bala et al. 2014). Recent studies indicate that
ethanol in the gut releases HMGB1 (Ge et al. 2014) which
activates TLR4 causing the gut to leak endotoxin LPS-like
bacterial products that stimulate proinflammatory cytokine in-
duction in the liver (Ge et al. 2014) thereby increasing circu-
lating blood cytokines (see Gao et al. 2011 for a review)
(Fig. 3). One mechanism involves ethanol causing the gut to
become more permeable or Bleaky.^ Indeed, this occurs pri-
marily with high doses of ethanol (i.e., at least 2–3 g/kg ETOH
intragastric doses [Ferrier et al. 2006]) that activate gut innate
immune signaling through disruption of gut tight junctions
that allows the gut microbiome bacteria and their endotoxins
to enter portal circulation leading to the liver inducing an
innate immune response in blood (Sims et al. 2010).
Alcoholism is associated with liver disease resulting in many
alcoholics having elevated levels of blood cytokines.
However, in healthy adults, an acute alcohol binge dose also
increases blood cytokines (Bala et al. 2014), and in human
alcoholics without liver disease, gut permeability is increased
during active drinking with increased blood endotoxin and
proinflammatory cytokines (Leclercq et al. 2012).
Interestingly, a 3-week period of abstinence led to a resolution
of gut permeability, but levels of circulating proinflammatory
cytokines (i.e., TNFα and IL-6) remained elevated across ab-
stinence. Furthermore, the authors found that serum levels of
circulating cytokines were correlated with levels of depression
and alcohol craving. These data suggest that ethanol-induced
gut permeability results in a peripheral blood innate immune
response that impacts brain and behavior (Leclercq et al.
2012). Systemic infection is associated with a constellation
of sickness behaviors including cognitive and emotive dys-
function, depression, fever, lethargy, and impaired memory
(Dantzer et al. 2008). In a randomized human study, subjects
that received a typhoid vaccination had elevated levels of cir-
culating IL-6 that was associated with sickness behavior
(Harrison et al. 2009a, b). Interestingly, the IL-6-induced re-
ductions of mood were associated with increased activity in
the anterior cingulate cortex during emotional face processing
as assessed using fMRI. Interestingly, connectivity of the an-
terior cingulate cortex, which has been implicated in the eti-
ology of depression, with the amygdala, medial prefrontal
cortex, and nucleus accumbens was reduced and associated
with circulating IL-6 (Harrison et al. 2009a). Proinflammatory
cytokines in the blood are actively transported across the
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blood–brain barrier (e.g., TNF receptor [Banks and Erickson
2010; Qin et al. 2007]) and also stimulate endothelial cells to
release cytokines in brain (Watkins et al. 1995) (see Fig. 3).
Thus, acute ethanol exposure can induce a blood cytokine
response by increasing endotoxin leak from the gut that can
lead to changes in the brain and behavior.
Induction of acute increases in blood levels of TNFα, other
cytokines, and ISM can have long-lasting effects on the brain.
For instance, Qin et al. (2007) found that a single systemic
dose of LPS increased mRNA and protein levels of TNFα in
parallel in the liver, blood, and brain, but the liver and blood
response subsided after 12–24 h, whereas the brain response
persisted for at least 10 months. However, in transgenic mice
lacking blood–brain barrier TNF receptor transporters, a sin-
gle systemic dose of LPS increased TNFα levels in the blood
but not in the brain suggesting that TNFα transport by its
receptor across the blood–brain barrier is necessary for acti-
vating proinflammatory neuroimmune responses in the brain.
As mentioned above, proinflammatory gene expression in
blood and brain parallels each other at early time points.
Surprisingly, the increase in proinflammatory gene expression
in the brain persisted for months leading to degeneration of
dopaminergic neurons of the substantia nigra that could con-
tribute to dopamine hypofunction leading to sensitization of
the response to the rewarding effects of ethanol (Blednov et al.
2011; Qin et al. 2007). Although the binge ethanol-induced
liver and blood responses are not as pronounced as LPS,
chronic ethanol pretreatment sensitizes systemic and brain
proinflammatory cytokine responses to a single systemic dose
of LPS following the conclusion of ethanol treatment through
TLR4 (Qin et al. 2008) and to a single systemic dose of poly
I:C through TLR3 (Qin et al. 2013). Ethanol appears to sen-
sitize microglia by upregulating multiple innate immune sig-
naling molecules, including TLR receptors (Crews et al.
2013). Chronic ethanol treatment of mice for 10 consecutive
days (5.0 g/kg, i.g.) increases brain expression of the proin-
flammatory cytokine monocyte chemotactic protein-1 (MCP-
1) that persists for at least 1 week of abstinence following
ethanol treatment (Qin et al. 2008). Exposure of C57BL/6J
mice to 10 daily doses of ethanol followed by a single system-
ic dose of LPS resulted in a potentiation of proinflammatory
cytokine induction in the liver, blood, and brain, resulting in
persistently higher brain expression long into abstinence rela-
tive to LPS alone-treated animals (Qin et al. 2008). In these
studies, ethanol sensitized mice to the LPS-induced
neuroimmune response that resulted in sustained increases in
multiple proinflammatory cytokines (e.g., TNFα, IL-1β, and
MCP-1) in the brain but not in the liver. While the mecha-
nism(s) of the sustained brain response and transient liver
response are not clear, we found that IL-10, an anti-
inflammatory factor that inhibits NF-κB, is increased in the
liver 1 week after alcohol treatment but decreased in the brain
(Qin et al. 2008). This finding is consistent with anti-
inflammatory mechanisms contributing to the reversal of the
Fig. 3 Ethanol in the gut causes leakage of bacterial products into the
portal vein increasing hepatic TNFα release into the blood which induces
neuroimmune gene expression in the brain. High doses of consumed
alcohol in the gut (i.e., at least 2–3 g/kg ETOH intragastric doses
[Ferrier et al. 2006]) increases permeability allowing bacterial products
such as endotoxin-lipopolysaccharide (LPS) to enter portal circulation.
Alcohol and LPS enter portal circulation leading to induction of liver
tumor necrosis factor-alpha (TNFα) and other proinflammatory
cytokines that are released into the blood and enter the brain through
cytokine-specific receptor transport (e.g., the TNFα receptor) (See Qin
et al. 2007 for details). This activates positive loops of proinflammatory
gene induction in the brain that all converge upon nuclear translocation of
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)
that amplify through autocrine and paracrine positive loops. Further,
ethanol causes nuclear release of high-mobility group box 1 (HMGB1)
and other danger associated molecular patterns (DAMPs) that enters the
extracellular space activating Toll-like receptors (TLRs) and the receptor
for advanced glycation end products (RAGE) in an autocrine and
paracrine fashion further amplifying NF-κB transcription. In parallel,
proinflammatory oxidases form reactive oxygen species (ROS) also
amplify activation of NF-κB transcription that can contribute to
inhibition of neurogenesis and cause neuronal death
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liver response. Bacterial products enter portal circulation acti-
vating Kupffer cells (i.e., liver monocytes) that produce cyto-
kines, including TNFα, that can be transported into the brain
where they activate brain neuroimmune signaling that persists
for long periods (Qin et al. 2007). Thus, the spread of a sys-
temic innate immune response to brain represents a mecha-
nism of brain neuroimmune gene induction.
Microglia and alcohol in the brain
Ethanol-induced hyper-ramified microglia have been impli-
cated in alcohol-induced activation of neuroimmune signaling
pathways in the brain. In rats, intermittent and chronic ethanol
exposure sensitize microglia, priming them for further activa-
tion and increasing expression of proinflammatory cytokines
providing indirect evidence for the role of microglia in
alcohol-induced neuroinflammation and neurotoxicity
(Alfonso-Loeches and Guerri 2011; Zhao et al. 2013).
Alcohol activates microglia via TLRs (Alfonso-Loeches and
Guerri 2011). Specifically, TLR4 expression and TLR4/TLR2
association on cultured microglia appear to be necessary for
alcohol-induced microglia activation with the production of
inflammatory mediators and cortical neuronal apoptosis
(Fernandez-Lizarbe et al. 2009, 2013). In an in vitro study
(Boyadjieva and Sarkar 2013b), application of microglial-
conditioned media enhanced ethanol-induced apoptosis of
cultured hypothalamic neurons. Interestingly, neutralization
of TNFα abolished the neuronal cell death induced by
microglial-conditioned media, suggesting that microglial pro-
duction of TNFα plays a key role in ethanol-induced neuro-
toxicity in developing neurons. Additionally, they found that
ethanol induces oxidative stress in neurons by increasing the
cellular production of O2
−, reactive oxygen species (ROS),
and nitrite while decreasing levels of the antioxidant glutathi-
one (GSH) and the cellular activity of other antioxidative en-
zymes, including glutathione peroxidase, catalase, and super-
oxide dismutase. Furthermore, treatment with either a synthet-
ic superoxide dismutase/catalase mimetic (EUK-134) or a
water-soluble analog of vitamin E (Trolox), both of which
are well-known antioxidants, protected developing hypotha-
lamic neurons from oxidative stress and cellular apoptosis
caused by ethanol-treated microglia media. These findings
are consistent with proinflammatory loops of positive feed-
forward amplification of neuroimmune signaling with multi-
ple components, including TLR receptors and proinflamma-
tory cytokines that contribute to neurodegeneration (Fig. 3).
Further, the P2X7R, which is a member of the purinergic P2X
family of ATP-gated ion channels, is highly expressed on
microglia and activation of these receptors is associated with
release of the proinflammatory cytokines IL-1β (Ferrari et al.
1997; Lister et al. 2007) and TNFα (Hide et al. 2000; Lister
et al. 2007). The functional responses of P2X7R activation by
ATP are associated with ongoing cellular damage and chronic
brain inflammation. Indeed, recent experimental evidence in-
dicates that stimulation of P2X7Rs mediate ATP-induced ap-
optosis through microglial production of superoxide
(Parvathenani et al. 2003; Raouf et al. 2007). Interestingly,
the P2X7 receptor might also play a role in microglial prolif-
eration since TNFα application to hippocampal-entorhinal
cortex slice culture led to an increased in proliferating microg-
lia (Zou et al. 2012). Thus, there are numerous processes
through which alcohol induces reactive oxygen species.
The systemic increases in proinflammatory signals broadly
activate neuroimmune signals across the brain (Sugama et al.
2009). In addition to neuroimmune cytokines, oxidases such
as COX-2, nitric oxide synthetasem and NADPH oxidase,
which includes phargocytic oxidase (e.g., gp91PHOX, which
was classically found increased in monocyte with phagocytic
morphology) form ROS that can contribute to neurotoxicity
(Takeuchi 2010). Reactive oxygen species are oxidative mol-
ecules that oxidize proteins, break down cell membranes, in-
duce cell death, and activate NF-κB as a component of proin-
flammatory amplification within and across cells (Fig. 3).
NADPH oxidase, a multi-subunit enzyme that catalytically
makes superoxide, is increased in the frontal cortex by both
a single systemic dose of LPS and 10 days of ethanol treat-
ment (5.0 g/kg, i.g.), particularly gp91PHOX, which is the su-
peroxide forming subunit (Qin and Crews 2012). These find-
ings are consistent with oxidative stress, through innate im-
mune gene induction, contributing significantly to alcoholic
brain damage in the orbitofrontal cortex. Qin et al. (2013)
found that a single systemic dose of LPS induces microglial
activation, NADPH oxidase, and oxidative stress that persist
for at least 20 months and leads to persistent neuroimmune
gene induction and a progressive persistent neurodegenera-
tion. The prolonged and persistent induction of NADPH oxi-
dase and oxidative stress in the brain could contribute to the
long-lasting increases in NF-κB transcription since oxidative
free radicals can activate NF-κB.
In addition to generation by activated microglia, ROS are
created as a natural by-product of alcohol metabolism and by
increased cellular respiration thereby creating an environment
of increased oxidative stress in the brain and glial cells that is
conducive to neuronal cell death (Guerri et al. 1994; Montoliu
et al. 1995). Several studies implicate microglia in alcohol-
induced production of ROS and consequent neurotoxicity.
For instance, Qin and Crews (2012) found that mice exposed
to chronic 10-day ethanol treatment (5.0 g/kg, i.g.) evidence
increased expression of NADPH oxidase (an enzyme that
produces ROS), O2
−, microglial activation, and cell death in
cortical and hippocampal brain regions. Interestingly, inhibi-
tion of NADPH oxidase decreased O2
−, microglial activation,
and neuronal cell death, linking alcohol-induced microglial
activation and neurotoxicity. Surprisingly, induced NADPH
oxidase in the brain was found in neurons in both mice
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exposed to chronic 10-day ethanol treatment (5.0 g/kg, i.g.)
and post-mortem human alcoholic orbitofrontal cortex (Qin
and Crews 2012) consistent with neuroimmune signaling am-
plifying across brain cell types. In agreement with the in vivo
findings, in vitro studies reveal that ethanol (25, 50, and
100 mM ethanol) dose-dependently increased induction of
oxidative stress (i.e., O2−, ROS, and nitrite) and apoptotic cell
death in neuronal hypothalamic primary cultures.
Interestingly, ethanol-activated microglial-conditioned media
potentiated ethanol-induced production of ROS and oxidative
stress in cultured hypothalamic neuronal cells leading to in-
creased apoptotic cell death (Boyadjieva and Sarkar 2013b).
Therefore, ethanol-activated neuroimmune signalingmay pro-
duce ROS and nitrite that decrease the cellular activity of anti-
oxidative enzymes and increasing expression of neuroimmune
molecules in neurons that contribute to neurodegeneration.
The mechanisms of alcohol-induced neurodegeneration
are complex involving multiple neuroimmune signals as
well as alterations in trophic signals (Crews and Nixon
2009; Guadagno et al. 2013). Ethanol induces IL-1β and
IL-6 as well as transforming growth factor-β1 (TGF-β1;
Alfonso-Loeches et al. 2010; Chen et al. 2006). One of
the cellular signaling mechanisms by which alcohol in-
duces neuronal apoptosis involves increased neuronal re-
lease of TGF-β1. It has been shown that alcohol-induced
increases of TGF-β1 levels in neuronal cells is accompa-
nied by increased expression of transcription factor E2F1
(overexpression sensitizes cells to apoptosis), reduced ex-
pression of cyclin D1 and cyclin-dependent kinase-4 (key
regulator of cell cycle progression), elevated levels of mi-
tochondrial pro-apoptotic proteins bak, bad, and bcl-xs,
lowered levels of the anti-apoptotic protein bcl-2, in-
creased production of apoptotic enzyme caspase-3, and
increased neuronal cell death (Chen et al. 2006; Kuhn
and Sarkar 2008). Hypothalamic neuronal cell cultures
following treatment with ethanol-activated microglial-
conditioned media showed decreased production levels
of cyclic adenosine monophosphate (cAMP) and brain-
derived neurotropic factor (BDNF; Boyadjieva and
Sarkar 2013a). Further, treatment with BDNF or dibutyryl
cAMP decreased ethanol-activated microglial-conditioned
medium-induced changes in intracellular free radicals,
ROS, and O2 as well as nitrite, GSH, and catalase.
Therefore, ethanol by increasing the production of
microglial-derived factors reduces cellular levels of
cAMP and BDNF leading to an increase in cellular oxi-
dative status and apoptosis of neuronal cells. Although
ethanol-induced sensitization of microglia leads to an in-
crease in the production of ISMs while also decreasing
trophic support that clearly contributes to altered neuronal
vitality and increase neuronal death, further studies are
needed to identify all the mechanisms by which ethanol-
activated signaling induces neurodegeneration.
Ethanol and neuronal excitation release HMGB1
triggering neuroimmune activation
A second mechanism of neuroimmune activation in brain in-
volves neuronal activation of adjacent microglia and astro-
cytes (Crews and Vetreno 2014; Sugama et al. 2009). This
form of neuroimmune activation in specific neuronal nuclei
may represent a form of neuroplasticity. Experience-induced
neuroimmune gene induction can lead to long-lasting changes
in neuronal excitability that could contribute to neuroplasticity
similar to synaptic long-term potentiation. Pathological in-
creases in excitability could contribute to mental diseases as
well as increasing sensitivity to excitotoxic neuronal death.
Excited neurons release HMGB1, also known as amphoterin
(Huttunen and Rauvala 2004), which stimulates microglia
thereby increasing NF-κB transcription of proinflammatory
cytokines (Crews et al. 2013; Zou and Crews 2014) as well
as increasing neuronal excitability (Maroso et al. 2010).
Microglia and astrocytes release cytokines increasing neuro-
nal excitability in part due to reduced glial uptake of glutamate
(Zou and Crews 2005) and increased glial release of glutamate
(Fig. 4) as well as neuronal HMGB1-TLR4 signaling that
enhances neuronal sensitivity to glutamate (Maroso et al.
2010). Ethanol-induced release of HMGB1 (Fig. 5) likely
contributes to adaptive changes in the brain that contribute
to alcoholic neuropathology, both the behavioral pathology
Fig. 4 Neuronal excitability releases HMGB1, which increases cytokine
secretion by microglia that activate astrocytes that increase glutamate
increasing neuronal excitability through glutamate, HMGB1, and other
signals. Glutamate, alcohol, and other factors release HMGB1 from
neurons causing microglia to become hyper-ramified, resulting in their
release of high-mobility group box 1 (HMGB1) and other
proinflammatory cytokines. These innate immune signaling molecules
stimulate astrocytes reducing glutamate uptake (Zou and Crews 2005)
and increasing astrocyte release of glutamate that induce neuronal
excitability causing further increases in HMGB1 release. Increased
neuronal hyperexcitability can contribute to potentiation of specific
neuronal connectivity and/or to excitotoxic neuronal cell death.
Figure adapted from Kettenmann et al. (2013)
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as well as neurodegeneration. However, it is still a matter of
debate whether neurons express the TLR4 receptor as our
group and others report evidence of neuronal TLR4 (Okun
et al. 2009; Vetreno et al. 2014; Vetreno and Crews 2012)
using immunohistochemistry, but other studies employing
fluorescence-activated cell sorting techniques suggest that
they are mostly expressed by glial cells (Schwarz and Bilbo
2013). Ethanol-induced release of HMGB1 results in the in-
duction of multiple neuroimmune molecules including TLR4
and TLR3 receptors as well as increased HMGB1 expression
(Fig. 5). The induction of agonists and receptors is character-
istic of innate immune responses that likely contribute to am-
plification and persistence of innate immune gene induction in
the brain. Actively released HMGB1 is acetylated, and we
discovered that ethanol increases HMGB1 acetylation through
altered histone deacetylases. Acetyl-HMGB1 is found in cy-
tosolic vesicles that is released during neuronal activation or
treatment with ethanol (Zou and Crews 2014). Release of
acetyl-HMGB1 by ethanol is consistent with active neuronal
release since cell death released HMGB1 is not acetylated.
The importance of ethanol-induced release of HMGB1 and
activation of TLR4 became apparent in large part due to the
elegant experiments of Consuelo Guerri’s laboratory. These
studies found that ethanol treatment induces neuroimmune
genes in microglia and astrocyte cultures as well as in vivo
in mice but not in transgenic cells or mice that lack TLR4
receptors (Alfonso-Loeches et al. 2010; Blanco et al. 2005;
Fernandez-Lizarbe et al. 2009; Pascual et al. 2011a; Valles
et al. 2004). The TLR4 receptor is constitutively expressed
on microglia, making them key components of drug-induced
neuroimmune activation (Fernandez-Lizarbe et al. 2009;
Schwarz and Bilbo 2013). More recent studies by Guerri’s
laboratory found that TLR4 is also integral to ethanol-
induced cortical neuronal death (Alfonso-Loeches et al.
2010), dopamine release (Pascual et al. 2009), damage to
white matter (Alfonso-Loeches et al. 2012), and other pa-
thologies associated with chronic alcohol-induced changes
in the brain (Pascual et al. 2011a). In hippocampal-
entorhinal cortex slice culture studies, ethanol treatment
increases innate immune gene expression in a time-
dependent fashion similar to responses to LPS or IL-1β
administration, although ethanol induces a much smaller
response in comparison (Crews et al. 2013; Zou and
Crews 2012). Primary culture studies allow for cell type-
specific analysis of the effects of ethanol on neuroimmune
gene induction. However, these culture techniques are lim-
ited in that they do not allow for assessment of the interac-
tion of neurons with glia. Indeed, by using hippocampal-
entorhinal cortex slice culture, which include neurons as
well as glial cells, we found that HMGB1 activity through
TLR4 is critically involved in the modulation of the innate
immune response to ethanol (Zou and Crews 2014). These
studies support the hypothesis that HMGB1-TLR4 signal-
ing underlies many of the effects of alcohol on the brain.
Although the culture studies indicate that ethanol can in-
duce neuroimmune genes in glial (Blanco et al. 2005;
Fernandez-Lizarbe et al. 2009) and brain slice cultures
(Zou and Crews 2010b, 2014), the in vivo studies in trans-
genic mice lacking TLR4 receptors (Alfonso-Loeches et al.
2010; Pascual et al. 2011a) likely blunt both ethanol-
induced systemic blood and the local neuronal responses.
These studies support HMGB1-TLR4 signaling in
neuroimmune gene induction by neuronal excitation and
ethanol. The loss of ethanol-induced dopamine responses
in mice lacking TLR4 receptors is consistent with HMGB1-
TLR4 induction of neuroimmune genes contributing to the
development of alcoholism as well as alcoholic neurode-
generation (Crews et al. 2011).
Fig. 5 Ethanol releases high-mobility group box 1 (HMGB1) leading to
activation of neuroimmune signaling. Ethanol causes the release of
HMGB1 into the media from hippocampal-entorhinal cortex (HEC)
slice culture. a Ethanol causes dose-dependent increase of HMGB1
release into culture media, relative to controls (* p<0.05, n=3). b
Western blot analysis of the whole cell lysate revealed that HMGB1
protein content increased progressively over time in response to ethanol
treatment (100 mM EtOH). c RT-PCR analysis found that ethanol
treatment (100 mM) for 4 days significantly increased Toll-like receptor
(TLR) 2, TLR4, and HMGB1mRNA in HEC slice culture (* p<0.05, n=
3). Data are adapted from Zou and Crews (2014)
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Ethanol induction of HMGB1-TLR signaling in the brain
Numerous studies support a significant role for neuroimmune
genes in contributing to alcoholism (Blednov et al. 2012;
Crews and Vetreno 2014; Crews et al. 2011; Osterndorff-
Kahanek et al. 2013). Human genetic studies find that poly-
morphisms of genes encoding IL-1β and other neuroimmune
genes are associated with susceptibility to the development of
alcoholism (Crews 2012; Marcos et al. 2008; Pastor et al.
2005). Neuroimmune gene expression is increased in human
alcoholic brains and correlates across rodent lines bred for
high and low alcohol consumption as models of alcoholism
(Flatscher-Bader et al. 2005; Liu et al. 2008; Mulligan et al.
2006). Further, LPS treatment increases brain immune gene
expression, and LPS treatment of high alcohol drinking
C57BL/6J mice results in a further increase in alcohol con-
sumption and preference that lasts for months (Blednov et al.
2011). The mechanism of increased alcohol drinking could
involve neuroimmune-induced dopamine hypofunction in
the ventral tegmental area sensitizing the brain to ethanol re-
ward (Blednov et al. 2011). Transgenic knock down of certain
neuroimmune genes in mice (Blednov et al. 2005, 2012) and
targeted disruption of TLR4 in the central amygdala (Liu et al.
2011) reduced alcohol consumption. In addition, pharmaco-
logical suppressions of various neuroimmune signaling path-
ways reduce alcohol intake in different animal models (Bell
et al. 2013; Mayfield et al. 2013). These studies suggest that
neuroimmune gene induction contributes to increased alcohol
drinking and alcoholism.
Studies investigating the mechanism of ethanol induction
of proinflammatory genes in the brain have led to the discov-
ery that chronic ethanol increases expression of TLRs as well
as the TLR4 receptor agonist HMGB1 (see Fig. 5). Ethanol
treatment of mice modeling 10 days of binge drinking (Crews
et al. 2013) and in vitro treatment of rat brain slice cultures
with ethanol for 4 days (Zou and Crews 2014) leads to in-
creased expression of HMGB1, TLR2, TLR3, and TLR4
mRNA, with immunohistochemistry suggesting that the in-
duction occurs largely in neurons (Crews et al. 2013).
Studies in post-mortem human alcoholic brain also find in-
creased expression of HMGB1, TLR2, TLR3, and TLR4
(Crews et al. 2013). Increased expression of receptors and
agonists are common in innate immune signaling and contrib-
ute to amplification within and across cells. Ethanol induction
of HMGB1 and TLR likely contributes to amplification of
neuroimmune gene induction in concert with neuronal excit-
ability (Fig. 4). Ethanol treatment of brain slice cultures finds
that HMGB1 antagonists, siRNATLR4 knockdown, and an-
tagonists block ethanol induction of proinflammatory genes
(Crews et al. 2013; Zou and Crews 2014). These studies sug-
gest that HMGB1-TLR signaling is central to ethanol induc-
tion of neuroimmune genes. However, TLRs and many cyto-
kine receptors are within the IL1-receptor family and share
kinase signaling cascades in the brain and glial cells that all
converge upon NF-κB (Blanco et al. 2005, 2008) confound-
ing which signals might be first. Interleukin-1β-IL1 receptor
signaling is linked to HMGB1-TLR signaling (Maroso et al.
2011). Interleukin-1β induction involves formation of the
inflammasome, unique intracellular multi-protein organelles
involved in the synthesis and secretion of IL-1β. We found
that ethanol treatment of hippocampal brain slice cultures in-
creased expression of IL-1β and NLRP-inflammasome pro-
teins as well as increased expression in post-mortem alcoholic
human hippocampus that with HMGB1-TLR signaling con-
tributed to ethanol-induced inhibition of neurogenesis (Zou
and Crews 2012). Although the mechanisms underlying
ethanol-induced innate immune gene induction in the brain
are complex involving many neuroimmune genes, HMGB1,
TLR, and other neuronal–glial neuroimmune signaling mole-
cules contribute to the neurobiology of alcoholism (Vetreno
and Crews 2014).
Persistence of neuroimmune gene induction in the brain
Although innate immune signaling in monocytes has many
similarities with neuroimmune signaling in microglia, as men-
tioned earlier, one difference appears to be that neuroimmune
action persists for long periods once activated. LPS treatment
of mice, which models the gut release of endotoxins (e.g.,
LPS) and human alcoholic hepatitis, results in rapid increases
in proinflammatory cytokines in the liver, blood, and brain,
with liver and blood levels returning within 24 h, whereas
brain microglial activation persists for months that after 7
and 10 months results in a progressive degeneration of
substantia nigra (SN) tyrosine hydroxylase (TH) expressing
dopamine neurons (Qin et al. 2007). Another study comparing
male and female C57BL/6J mice found that males show de-
layed (7 months) loss of SN dopaminergic neurons after a
single LPS dose. However, females requiredmultiple monthly
LPS treatments that after 7 and 20 months later showed an
approximate 40 to 50 % loss of SN TH-IR DA neurons and
reduced rotor-rod ability that was transiently restored by L-
dopa/carbidopa treatment (Liu et al. 2008). Neuroimmune
signaling across and within brain cells likely contributes to
loops of neuroimmune-NF-κB activation that include NADP
H oxidase, the enzyme that makes reactive oxygen species
described earlier (Qin and Crews 2012).
Initial studies of alcohol and innate immune responses
were confounded by the ethanol blockade of LPS-TLR4 sig-
naling in monocytes and possibly other immune cells (Crews
et al. 2006, 2011; Szabo and Mandrekar 2009). Szabo’s group
reported that ethanol (25 mM) in vitro blunts LPS induction of
TNFα (Szabo et al. 1995). Similarly, acute ethanol exposure
attenuates TNFα, IL-1β, and IL-6 immune responses to LPS
during intoxication (Pruett et al. 2004) that contrast with
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findings of in vivo chronic ethanol exposure modeling binge
drinking that involve cycles of ethanol exposure and absti-
nence that cause progressive induction of HMGB1-TLR-
RAGE expression and sensitization to neuroimmune activa-
tion. Indeed, models of moderate drinking find that multiple
cycles cause transient neuroimmune induction in the brain
(Whitman et al. 2013), whereas binge drinking models that
utilize doses consistent with binge levels of ethanol (e.g.,
5.0 g/kg, i.g.) induce persistent increases in the brain
neuroimmune genes and proteins including HMGB1, TLR,
and RAGE in adolescent rats (Vetreno and Crews 2012;
Vetreno et al. 2013) and adult mice (Qin and Crews 2014;
Qin et al. 2007, 2008). Similarly, studies of post-mortem hu-
man brain find that expression levels of HMGB1 and TLR in
orbital frontal cortex (OFC) correlate with lifetime alcohol
consumption across normal and alcoholic humans (Crews
et al. 2013). This interesting correlation could only occur if
ethanol induction of HMGB1-TLR receptors was persistent
and cumulative with binge drinking episodes. Interestingly,
treatment of adolescent rats modeling underage binge drink-
ing induces HMGB1, TLR4, and RAGE that continue to un-
dergo developmental changes in the brain (Fig. 6). HMGB1,
TLR, and RAGE induction persists into abstinence, with
TLR4 and RAGE showing developmental decreases in the
frontal cortex and HMGB1 showing a developmental in-
crease. Multiple other neuroimmune genes remain induced
in adulthood (Fig. 6). Risk of alcohol dependence increases
with a younger age on drinking onset (Fig. 7), and post-
mortem prefrontal cortex expression also correlates with age
of drinking onset (Fig. 7) (Vetreno et al. 2013). Together, these
studies suggest that the persistent increase in brain HMGB1-
TLR4 and neuroimmune signaling contribute to the chronic
relapsing nature of alcoholism and the slow progressive de-
generation found in alcoholism (Crews and Nixon 2009).
While induction of the innate immune system through
NF-κB signaling cascades has been implicated in alcohol-
induced neurodegeneration, recent evidence suggests that a
shift in neurotrophic/innate immune signaling might also be
involved. Cyclic AMP-responsive element binding protein
(CREB) and many of its target genes, including neuropeptide
Y (NPY) and brain-derived neurotrophic factor (BDNF), pro-
mote neuronal survival and protect neurons from
excitotoxicity and apoptosis (Lonze and Ginty 2002). Levels
of CREB-DNA binding, phosphorylated CREB, and BDNF
Fig. 6 Adolescent intermittent ethanol (AIE) treatment leads to a
persistent induction of neuroimmune genes in the adult brain. a Male
Wistar rats were treated with ethanol (5 g/kg/day, i.g., w/v, 2 days on/
2 days off) or comparable volumes of water from postnatal day (P)25 to
P55. Brain tissue was collected either 24 h (P56) or 25 days after the last
ethanol treatment (P80) to assess the persistent expression of
neuroimmune markers. Toll-like receptor 4 (TLR4) immunoreactivity
was upregulated 24 h after ethanol treatment and remained elevated for
25 days following the conclusion of ethanol treatment. In contrast, there
was no change in receptor for advanced glycation end-product (RAGE)
expression immediately following the conclusion of ethanol treatment but
was elevated 25 days after the conclusion of ethanol treatment.
Expression of high-mobility group box 1 (HMGB1), an endogenous
TLR4 and RAGE agonist, was increased both 24 h and 25 days
following the conclusion of ethanol treatment. b In a separate cohort of
subjects, frontal cortex tissue samples were collected from CON- to AIE-
treated animals on P80 (25 days following the conclusion of ethanol
treatment) and neuroimmune gene mRNA levels were assessed.
Adolescent binge ethanol treatment led to long-term upregulation of
proinflammatory cytokines (tumor necrosis factor-alpha [TNFα] and
monocyte chemotact ic prote in-1 [MCP -1 ] ) and oxidases
(cyclooxygenase [COX-2] and gp91PHOX [NOX2]). **p<0.01, relative
to CONs. Data are adapted from Vetreno and Crews (2012) and
Vetreno et al. (2013)
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are decreased in the rat frontal cortex following a 24-h with-
drawal from chronic ethanol exposure (Pandey et al. 1999,
2001). Further, cortical levels of NPY are reduced by ethanol
treatment, which was accompanied by a reduction of
phosphorylated CREB (Bison and Crews 2003) .
Interestingly, our laboratory found that ethanol dose-
dependently reduces CREB-DNA binding while simulta-
neously increasing NF-κB-DNA binding in hippocampal-
entorhinal cortex slice culture (Zou and Crews 2006).
However, following a prolonged period of abstinence,
CREB level has been shown to rebound (Bison and Crews
2003), which could contribute to the recovery of white matter
volume and cognitive function associated with protracted ab-
stinence (Pfefferbaum et al. 1995; Sullivan et al. 2000a, b).
Although this review highlights HMGB1-TLR4 signaling,
there are multiple other proinflammatory genes that are in-
creased, and we have found many in the post-mortem human
alcoholic brain (see Table 1). Initial studies found increased
markers of microglia and the proinflammatory cytokine
MCP1 (CCL2) post-mortem alcoholic ventral tegmental area,
amygdala, nucleus accumbens, and hippocampus (He and
Crews 2008). However, populations of activated microglia
in other brain regions remain to be determined in the human
post-mortem alcoholic brain. In studies focused on the PFC,
we found that post-mortem alcoholic brain has increased
levels of HMGB1 as well as TLR2, TLR3, and TLR4 recep-
tors (Crews et al. 2013) and RAGE (Vetreno et al. 2013).
Similarly, NADPH oxidase is increased in alcoholic
PFC, the brain region most insulted in alcoholics (Crews
and Nixon 2009; Qin and Crews 2012). In other studies
focused on hippocampal neurogenesis, we found in-
creased IL-1β inflammasome markers in the hippocampus
of post-mortem alcoholic brain (Zou and Crews 2012).
These studies indicate that multiple neuroimmune genes
are upregulated in the human alcoholic brain and likely
contribute to neurodegeneration and the neurobiology of
alcoholism. These findings further support the role of
neuroimmune signaling in human alcoholism and alcohol-
ic neurodegeneration.
Fig. 7 Risk of alcoholism and induction of innate immune genes
correlate with age of drinking onset in humans. a Toll-like receptor 4
(TLR4) and high-mobility group box 1 (HMGB1) expression in the
post-mortem human brain is negatively correlated with age of drinking
onset adapted from Vetreno et al. (2013). b An earlier age of drinking
onset is predictive of an increased likelihood of developing an alcohol use
disorder during an individual’s lifetime. Adapted from Grant (1998)
Table 1 Neuroimmune markers
are increased in post-mortem
human alcoholic brain
Marker Full name Effect Citation
RAGE Receptor for advanced glycation end products ↑ Vetreno et al. (2013)
TLR2 Toll-like receptor 2 ↑ Crews et al. (2013)
TLR3 Toll-like receptor 3 ↑ Crews et al. (2013)
TLR4 Toll-like receptor 4 ↑ Crews et al. (2013)
HMGB1 High-mobility group box 1 ↑ Crews et al. (2013)
IL-1β Interleukin-1β ↑ Zou and Crews (2012)
NALP1 Nacht, leucine-rich repeat and pyrin domain
containing protein
↑ Zou and Crews (2012)
gp91phox NADPH oxidase 2 ↑ Qin and Crews (2012)
MCP-1 (CCL2) Monocyte chemotactic protein 1 (chemokine
[C-C motif] ligand 2)
↑ He and Crews (2008)
Iba-1 Ionized calcium-binding adapter molecule 1 ↑ He and Crews (2008)
GluT5 Microglia marker ↑ He and Crews (2008)
MK Medkine ↑ Flatscher-Bader et al. (2005)
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Neuroimmune signaling, hyperexcitability, and neuronal
death
Excitotoxicity is associated with alcoholic neurodegeneration
and HMGB1-TLR4 signaling. Chronic ethanol treatment of
neurons leads to increased sensitivity to excitotoxicity
(Chandler et al. 1994). Ethanol potentiates glutamate
excitotoxicity in brain slice cultures due to blockade of glial
transporters (Zou and Crews 2010). However, in neuronal
primary cultures, ethanol blocks N-methyl-D-aspartate
(NMDA) excitotoxicity consistent with many studies finding
ethanol inhibition of NMDA receptors (Chandler et al. 1998).
Similar to acute ethanol blocking TLR4 receptor activation
when present, ethanol blocks NMDA receptors when present
(Chandler et al. 1998). Although ethanol can block NMDA
responses, glutamate excitotoxicity is increased by ethanol
and TNFα in brain slice cultures due in part to glial loss of
glutamate uptake (Zou and Crews 2005) and perhaps release
by ethanol. Further, HMGB1-TLR4 signaling has been shown
to activate kinase cascades that lead to phosphorylation of the
NR2B subunit of NMDA receptors causing the migration of
more NMDA receptors to the synapse that increase synaptic
NMDA receptors, neuronal excitability, and excitotoxicity
(Balosso et al. 2014; Maroso et al. 2010). Both HMGB1-
TLR4 signaling (Balosso et al. 2014) and IL1β-IL1R signal-
ing (Viviani et al. 2003) have been shown to increase NMDA
receptor-mediated calcium flux, neuronal excitability, and
excitotoxicity through activation of kinase cascades. IL1β-
IL1R activation of the Src kinase has been found to increase
NMDA calcium flux, excitability, and excitotoxicity. Many
studies have found that tyrosine-kinase activation can increase
excitability through increases in NR2B-NMDA receptor
phosphorylation. Dorit Ron’s group has found that ethanol
increases NMDA excitability in hippocampus through kinase
activation that alters receptor trafficking leading to increased
NR2B-NMDA receptors and increased excitability (Suvarna
et al. 2005). Another mechanism of chronic ethanol-induced
hyperexcitability is neuroimmune inhibition of glial glutamate
transporters (Zou and Crews 2005). Ethanol releases HMGB1
creating hyperexcitability that disrupts synaptic plasticity and
sensitizes to excitotoxicity. HMGB1 is massively released
during brain damage activating persistent neuroimmune gene
induction (Kim et al. 2006). Indeed, Maroso et al. (2010)
found increased release of HMGB1 with hippocampal excit-
ability that caused seizures leading to persistent increases in
HMGB1 and excitability. Ethanol has a modest cumulative
effect that, with repeated chronic exposure, increases excit-
ability and excitotoxicity due to increased neuroimmune sig-
naling (see Fig. 4). Thus, the global neurodegeneration with
the most severe losses in frontal cortex found in alcoholism is
secondary to the persistent and progressive neuroimmune ac-
tivation that occurs during alcoholism, which is a chronic
relapsing disorder.
Summary
Alcoholism is associated with increased neuroimmune gene
expression in the brain. Neuroimmune gene induction appears
to occur through two processes, systemic induction of innate
immune genes resulting from alcohol-induced increases in gut
permeability that result in increased blood cytokines that acti-
vate brain neuroimmune genes through multiple mechanisms
including transport from blood into the brain. These signals
activate neurons and glia through complex signaling that in-
cludes amplification through convergence of signaling
through NF-κB and AP-1 pathways leading to the induction
of proinflammatory cytokines, TLR receptors, RAGE, NADP
H oxidase, and other oxidases. Ethanol also induces HMGB1
that contributes to positive loops of amplification of
neuroimmune genes through TLR receptors and RAGE.
Persistent activation of these pathways leads to a hyperexcit-
able state that disrupts neuronal networks contributing to al-
coholic psychopathology as well as neurodegeneration.
Agents that block ethanol neuroimmune activation may be
able to prevent alcoholism and alcoholic neurodegeneration.
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